Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
06:15 EDT 28 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
UNION CITY, Calif., June 28, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a company manufacturing point of care instrumentation and consumables for the medical, veterinary, and research markets, announced today that a leading international medical s...
Other Sources for this Article
More From BioPortfolio on "Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
